{Reference Type}: Journal Article
{Title}: Nursing care for chimeric antigen receptor T cell therapy survivors: A literature review.
{Author}: Montoro-Lorite M;Moreno C;Ramos C;Solano MT;Lahoz S;Bonilla-Serrano C;Domènech A;Ayora P;
{Journal}: Asia Pac J Oncol Nurs
{Volume}: 11
{Issue}: 6
{Year}: 2024 Jun
{Factor}: 2.22
{DOI}: 10.1016/j.apjon.2024.100495
{Abstract}: Chimeric antigen receptor T cell (CAR-T) therapy is an immunotherapy that involves genetically modifying the patient's own T cells to express a chimeric antigen receptor, enabling them to recognize and destroy cancer cells. This treatment has revolutionized the prognosis and management of hematological malignancies, leading to a significant increase in long-term survivors. However, there is limited evidence regarding late sequelae and post-treatment care due to the recent emergence of this therapy. The rapid advancement of CAR-T therapies has created opportunities for advanced practice nurses to play a crucial role in coordinating care, providing education, and ensuring the ongoing well-being of survivors. This article provides an overview of the physical, psychosocial, and financial challenges faced by long-term survivors of CAR-T therapy and proposes a comprehensive nursing care plan to address these issues.